Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

INDOL1 Inhibitors

INDOL1 inhibitors belong to a chemical class of compounds that target the INDOL1 enzyme. INDOL1, also known as indoleamine 2,3-dioxygenase-like 1, is a member of the indoleamine 2,3-dioxygenase (IDO) family of enzymes. The IDO family plays a crucial role in tryptophan metabolism, converting tryptophan to kynurenine. This enzymatic reaction is involved in various physiological processes, including immune response regulation and neurotransmitter synthesis. By inhibiting INDOL1, these compounds may interfere with its enzymatic activity and consequently affect tryptophan metabolism and the production of kynurenine. This could potentially have an impact on the immune system and neurotransmitter signaling, as these processes are tightly regulated by tryptophan metabolites. Understanding the role of INDOL1 inhibitors is an important area of research, as it can shed light on the intricate mechanisms of tryptophan metabolism and its significance in various biological processes. However, the specific applications and potential implications of INDOL1 inhibitors are still under investigation, and further studies are required to fully elucidate their effects on cellular and physiological functions.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

1-Methyl-D-tryptophan

110117-83-4sc-200313
50 mg
$52.00
3
(1)

1-Methyl-D-tryptophan is a unique indole derivative that exhibits distinct molecular interactions through its methylation at the nitrogen atom. This modification alters its electronic properties, enhancing its ability to engage in hydrogen bonding and π-π stacking with aromatic residues in proteins. Its presence can influence tryptophan metabolism pathways, potentially modulating the activity of enzymes involved in serotonin synthesis. The compound's stereochemical configuration also plays a crucial role in its reactivity and binding affinity, affecting downstream signaling cascades.

INCB024360

914471-09-3sc-488722
25 mg
$300.00
(0)

INCB14943 is a selective IDO2 inhibitor developed by Incyte Corporation.

Taurine

107-35-7sc-202354
sc-202354A
25 g
500 g
$48.00
$102.00
1
(1)

Some studies have reported taurine-conjugated IDO2 inhibitors with potential selectivity.

NLG919

1402836-58-1sc-478118
10 mg
$352.00
(0)

NLG-919 is another dual inhibitor targeting both IDO1 and IDO2.